Full-Time

Manager – Medical Information

Confirmed live in the last 24 hours

Axsome Therapeutics Inc

Axsome Therapeutics Inc

201-500 employees

Develops therapies for CNS disorders

Biotechnology
Healthcare

Compensation Overview

$118k - $128kAnnually

+ Bonus + Equity

Mid, Senior

New York, NY, USA

On-site requirement of at least three days per week.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • Advanced degree required. PharmD preferred
  • Minimum of 1-2 years of pharmaceutical/biotechnology industry-based medical information experience required. Will consider relevant Fellowships
  • Understanding of applicable regulations that govern medical information activities
  • Proven ability to effectively research, interpret, and assess medical/scientific data. Proficient in searching medical literature databases
  • Ability to work on site Monday, Tuesday & Thursday
Responsibilities
  • Provide high quality, balanced, and timely responses to unsolicited medical and pharmaceutical inquiries regarding Axsome products from healthcare professional and consumers.
  • Develop evidence-based standard and custom response documents and FAQ responses on topics related to Axsome products.
  • Provide training to call center on medical information content and processes
  • Work with call center in handling inquiries requiring escalation and customized responses
  • Assist with review of content in promotional and medical materials to assure scientific rigor and quality
  • Maintain a high level of product and disease state expertise to produce the highest quality of medical information support to both internal and external customers.
  • Continuous monitoring of medical information inquiry trends to ensure appropriate content strategy and as well as communication to the wider organization
  • Support medical information booth activities during professional scientific meetings/medical congresses.
  • Continuous improvement of Medical Information processes and deliverables
  • Understand and comply with appropriate ethical, legal, and regulatory standards, including those for responding to unsolicited requests for product information.
  • Identify and report adverse events and product quality complaints to Pharmacovigilance and Quality Assurance per corporate policies.
  • Ad hoc project support as needed for efforts in Medical Information and Medical Affairs.
Axsome Therapeutics Inc

Axsome Therapeutics Inc

View

Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain to help regulate mood. This drug has shown positive results in clinical trials and has received FDA Breakthrough Therapy Designation, which speeds up its development process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and clinical trials. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.

Company Stage

IPO

Total Funding

$430.7M

Headquarters

New York City, New York

Founded

2012

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Growing mental health awareness expands the market for Axsome's treatments.
  • FDA's approval of digital therapeutics aligns with Axsome's CNS treatment strategies.
  • Telemedicine rise offers Axsome opportunities to enhance patient adherence and reach.

What critics are saying

  • Increased competition in CNS treatments may impact Axsome's market share.
  • Departure of key executive Lori Englebert could disrupt business strategies.
  • Delays in clinical trials or approvals could hinder product market entry.

What makes Axsome Therapeutics Inc unique

  • Axsome focuses on CNS disorders, addressing unmet medical needs in mental health.
  • AXS-05, an NMDA receptor antagonist, has FDA Breakthrough Therapy Designation.
  • Axsome's balanced portfolio includes both clinical and research stage products.

Help us improve and share your feedback! Did you find this helpful?